Including Foraminous Material (e.g., Sponge, Etc.) Or Fibrous Element Other Than Withdrawal Cord Patents (Class 604/286)
-
Patent number: 11969317Abstract: A wound dressing includes an inelastic absorbent layer, an elastic film, and a plurality of welds. The inelastic absorbent layer is configured to absorb wound fluid and has a first side and a second, wound-facing side. The elastic film is configured to elastically stretch when a stretching force is applied to the wound dressing and elastically recover when the stretching force is removed. The plurality of welds fix the elastic film to the first side of the inelastic absorbent layer such that the elastic film and the inelastic absorbent layer elastically stretch and elastically recover as a unit.Type: GrantFiled: May 21, 2018Date of Patent: April 30, 2024Assignee: 3M Innovative Properties CompanyInventors: Christopher B. Locke, Benjamin A. Pratt, Alexander Waite
-
Patent number: 11369632Abstract: The present invention relates to a composition based on components of natural origin, in particular ozonized olive oil and liquid vegetable extracts, for the topical treatment of vaginosis and/or vulvovaginitis of bacterial and/or fungal origin.Type: GrantFiled: April 4, 2018Date of Patent: June 28, 2022Assignee: Organicare LLCInventors: Franco Papa, Renato Colognato
-
Patent number: 11298514Abstract: A device for dispensing a foam medication into a human or animal ear includes a supply of foamable medicine held within a container. The medicine is advanced through a delivery tube that is configured to engage an ear without entering the ear canal to an extent that it contacts the eardrum. The delivery tube has an enlarged end portion that prevents the device from being inserted too far into an ear, and the enlarged end portion has a series of openings oriented in two different directions to deliver foam into the ear forward of the device and around the circumference of the delivery tube.Type: GrantFiled: October 28, 2019Date of Patent: April 12, 2022Inventor: Roy J. Martin
-
Patent number: 11207199Abstract: A stent is disclosed that has an elongated body composed of a bioabsorbable polymer having a proximal end, a distal end, two open spiral channels formed on the exterior surface of the body to provide fluid communication between the proximal end and the distal end. The stent has a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire. The stent also has an anti-migration device used for immobilization of the stent at the target site.Type: GrantFiled: March 19, 2019Date of Patent: December 28, 2021Assignee: Q3 MEDICAL DEVICES LIMITEDInventor: Eric K. Mangiardi
-
Patent number: 11147714Abstract: An apparatus for cleansing wounds in which irrigant fluid from a reservoir connected to a conformable wound dressing and wound exudate from the dressing are moved by a device (which may be a single pump or two pumps) for moving fluid through a flow path which passes through the dressing and a means for providing simultaneous aspiration and irrigation of the wound. The apparatus also comprises means to apply high frequency vibrational energy, e.g. ultrasound, to the wound bed. The former removes materials deleterious to wound healing, while distributing materials that are beneficial in promoting wound healing over the wound bed. The latter promotes healing. The dressing and a method of treatment using the apparatus.Type: GrantFiled: July 25, 2018Date of Patent: October 19, 2021Assignee: Smith & Nephew PLCInventors: Patrick Lewis Blott, Clare Green, Edward Yerbury Hartwell, Robin Paul Martin, Derek Nicolini, Julian Lee-Webb
-
Patent number: 11083879Abstract: A vaginal detoxing kit comprises a vaginal insert apparatus and a hollow tube. The vaginal insert apparatus comprises a pearl shaped body and a string. Further, the pearl shaped body comprises a plurality of herbal ingredients. The string is fixedly attached to the pearl shaped body and wrapped around it. The hollow tube comprises first and second openings. A user unravels the string, inserts the string into a first opening, and draws the string through the second opening of the hollow tube. The vaginal insert apparatus is seated against the first opening of the hollow tube. The user wraps the drawn out string around a finger of the user to ensure the vaginal insert is seated firmly against the first opening. The user inserts the vaginal insert apparatus inside a vagina of the user to perform vaginal detoxing of an interior of the vagina.Type: GrantFiled: March 29, 2017Date of Patent: August 10, 2021Inventor: Vanessa White
-
Patent number: 10894153Abstract: This disclosure describes example antimicrobial compositions that may be used in combination with IV port cleansing caps, protective caps, or both. According to another implementations, the disclosure describes various cap devices that may be used in combination with the antimicrobial composition to cleanse, sanitized, and/or disinfected a surface.Type: GrantFiled: March 11, 2019Date of Patent: January 19, 2021Assignee: Hyprotek, Inc.Inventor: Patrick O. Tennican
-
Patent number: 10765415Abstract: A hemostatic device for sealing a puncture of a vessel includes a first tube defining a first lumen. The first lumen is configured to receive a guidewire and a flow of a fluid therethrough. The hemostatic device also includes a second tube circumscribing at least a portion of the first tube and at least partially defining a second lumen. The hemostatic device further includes a substantially rigid stopper coupled to a distal end of the second tube. The stopper defines a stopper lumen that receives the first tube therethrough in an interference fit. A first opening is defined in a side wall of the first tube and positioned distally relative to the stopper. At least one injection groove defined in an outer surface of the stopper cooperates with the distal end of the second tube to define at least one second opening in flow communication with the second lumen.Type: GrantFiled: May 10, 2018Date of Patent: September 8, 2020Assignee: Phillips Medical, LLCInventor: Victor Matthew Phillips
-
Patent number: 10562472Abstract: Systems and apparatuses include a passive device coupled to a mounting boss arranged on a vehicle system, and a sensor structured to engage the mounting boss. The sensor includes a probe structured to sense a characteristic of the vehicle system, and a reader structured to send a query signal to the passive device and receive location data from the passive device associated with the mounting boss.Type: GrantFiled: January 12, 2018Date of Patent: February 18, 2020Assignee: Cummins, Inc.Inventors: Ganesh Raghunath, Alok A. Joshi, Shu Li
-
Patent number: 10556043Abstract: An apparatus for use in a multi-orientation liquid collection canister to collect liquid from a tissue site is provided. The apparatus includes a substantially planar, liquid-air separator disposed on at least one wall of the multi-orientation liquid collection canister to prevent the liquid from exiting the multi-orientation liquid collection canister. The apparatus further includes an elongated member connected to the liquid-air separator and extending away from the liquid-air separator into a first space of the multi-orientation liquid collection canister. The elongated member has a membrane defining a second space along at least a portion of a length of the elongated member. At least a portion of the membrane allows gaseous communication between the first space and the second space.Type: GrantFiled: September 9, 2016Date of Patent: February 11, 2020Assignee: KCI Licensing, Inc.Inventors: Christopher Brian Locke, James A. Luckemeyer
-
Patent number: 10245189Abstract: A tampon for feminine hygiene, having an insertion end, a recovery end, a recovery tape, and a longitudinal axis. The tampon is made of compressed fibrous material and has an outer surface that is at least partially provided with spirally shaped, pressed longitudinal grooves. The grooves define spirally shaped longitudinal ribs. Also disclosed is a method for producing the tampon.Type: GrantFiled: May 28, 2014Date of Patent: April 2, 2019Assignee: Edgewell Personal Care Brands, LLCInventor: Hans Werner Schoelling
-
Patent number: 9687387Abstract: An apparatus for insertion in an ear is provided in one example and includes a drug delivery device for insertion into an external auditory canal, wherein the drug delivery device contains one or more pharmaceutically active agents that can be released from the drug delivery device into the external auditory canal. In more particular instances, the drug delivery device can conform to the profile of the external auditory canal.Type: GrantFiled: September 14, 2012Date of Patent: June 27, 2017Inventor: Yoseph Yaacobi
-
Patent number: 9610201Abstract: A tampon absorbent for insertion into a vaginal cavity is provided. The tampon absorbent includes a longitudinal direction and has an insertion end and a withdrawal end. The tampon absorbent includes a first absorbent material portion at the insertion end for capturing body fluid and demonstrating a first expansion capacity, and a second absorbent material portion at the withdrawal end for storing body fluid and demonstrating a second expansion capacity. The second absorbent material portion is partially wrapped around the first absorbent material portion in a direction transverse (perpendicular) to the longitudinal direction, at a bonding region, whereby the first absorbent material portion is bonded to the second absorbent material portion at the bonding region.Type: GrantFiled: April 30, 2012Date of Patent: April 4, 2017Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Alexander Schmidt-Foerst, Mary L. McDaniel, Charles R. Tomsovic, Garry R. Woltman
-
Patent number: 9545466Abstract: A reduced pressure treatment system includes a control unit having a control system and a reduced pressure source. The reduced pressure treatment system further includes a manifold unit in fluid communication with the reduced pressure source and a component module to augment treatment. The component module is configured to communicate with the control system of the control unit, and the component module includes a first mounting region configured to be coupled to a complimentary mounting region of the control unit. The component module further includes a second mounting region identical to the complimentary mounting region of the control unit to allow a second component module to be coupled to the first component module.Type: GrantFiled: March 17, 2016Date of Patent: January 17, 2017Assignee: KCI Licensing, Inc.Inventors: Christopher Brian Locke, Timothy Mark Robinson, Mark Stephen James Beard, Aidan Marcus Tout
-
Patent number: 9259360Abstract: There is provided a tampon pledget that includes one or more enhanced features that result in the pledget exhibiting increased bypass leakage prevention. These enhanced features may include, but are not limited to, geometry, absorption, and any combinations thereof. There is also provided one or more methods for constructing a tampon pledget having increased bypass leakage protection.Type: GrantFiled: December 2, 2010Date of Patent: February 16, 2016Assignee: Edgewell Personal Care Brands, LLC.Inventors: Robert Jorgensen, Keith Edgett
-
Publication number: 20150038941Abstract: An orthopaedic implant system includes an external fixation device implantable at a selected location within a corporeal body and configured for delivering at least one therapeutic agent to the corporeal body. The external fixation device includes an implantable pin, a sheath coupled with the pin, a reservoir coupled with the sheath and a plurality of channels. The pin defines the plurality of channels. The reservoir is configured for receiving the at least one therapeutic agent. The plurality of channels are configured for conveying the at least one therapeutic agent from the reservoir to a treatment site relative to the corporeal body.Type: ApplicationFiled: October 2, 2014Publication date: February 5, 2015Applicant: SMED-TA/TD, LLCInventors: Paul S. Nebosky, Sarah L. Zimmerman, Gregory C. Stalcup, Troy D. Knapp
-
Patent number: 8945038Abstract: A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.Type: GrantFiled: May 17, 2013Date of Patent: February 3, 2015Assignee: Transcend Medical, Inc.Inventor: Michael Yablonski
-
Publication number: 20150011951Abstract: The present invention relates to an implant that is implanted into a human body by means of osseointegration. A drug delivery system comprises: an implant (10) for performing a support function, which is implanted into a human body; and a cover unit (20) for performing a covering function, which is coupled to the implant (10). The drug delivery system further comprises: an accommodating unit (12) formed in the implant (10) for accommodating a drug cartridge (30) and intended to be opened/closed by the cover unit (20); a plurality of diffusion units (14) formed in the wall surface of the accommodating unit (12) so as to diffuse and discharge contents of the drug cartridge (30); and injection units (16) formed at the respective ends of the diffusion units (14) for injecting the contents of the drug cartridge (30) into the human body.Type: ApplicationFiled: June 18, 2012Publication date: January 8, 2015Applicants: SNU R&DB FoundationInventors: Chee Il Hwang, Shin Jae Lee, Young Seok Park
-
Publication number: 20150005595Abstract: Devices for the local delivery of microdose amounts of one or more active agents, alone or in combination, in one or more dosages, to selected tissue of a patient are described. The devices generally include multiple microwells arranged on or within a support structure and contain one or more active agents, alone or in combination, in one or more dosages and/or release pharmacokinetics. In an exemplary embodiment, the device has a cylindrical shape, having symmetrical wells on the outside of the device, each well containing one or more drugs, at one or more concentrations, sized to permit placement using a catheter, cannula, or stylet. Optionally, the device has a guidewire, and fiber optics, sensors and/or interactive features such as remote accessibility to provide for in situ retrieval of information and modification of device release properties. In a preferred embodiment, the fiber optics and/or sensors are individually accessible to discrete wells.Type: ApplicationFiled: June 6, 2014Publication date: January 1, 2015Inventors: Robert I. Tepper, Jason Fuller, Oliver Jonas, John Santini
-
Publication number: 20140371687Abstract: The present invention provides a device including a titania nanotube membrane having a plurality of titania nanotubes on a titanium substrate where the titania nanotubes are open at both ends and capable of allowing diffusion of liquids or solids from one side of the membrane to the other through the titania nanotubes. Methods of making the titania nanotube membrane are also provided.Type: ApplicationFiled: December 5, 2012Publication date: December 18, 2014Inventors: Adam D. Mendelsohn, Kathleen E. Fischer, Lily H. Peng, William G. Fischer
-
Publication number: 20140309610Abstract: This application provides a device for delivering a beneficial substance to a patient. The device comprises a shell enclosing a plurality of carrier particles. The carrier particles are porous, and a beneficial substance, such as a drug, is disposed in the pores. The drug can diffuse out of the pores, into the interior of the device, and then through at least one permeable portion of the shell. This application also provides methods of making and using these devices.Type: ApplicationFiled: March 12, 2014Publication date: October 16, 2014Applicant: pSivida Corp.Inventors: Leigh T. Canham, Hong Guo, Martin Nazzaro, Christian Barnett
-
Publication number: 20140271919Abstract: Copper ion treatments and methods of treatment are provided to treat various body conditions affecting the genital and/or rectal areas. The copper ion treatments contain a copper ion-containing solution which, as a result of the copper ions contacting anatomical tissue of the vagina, the rectal canal and/or the external genital or rectal areas, brings about local and systemic therapeutic effects. The copper ion treatments and methods for treating conditions affecting the genital and/or rectal areas involve the use of tampons, suppositories, lotions, creams, gels, foams and solutions, each containing a copper ion-containing solution. The tampon bodies and the copper ion lotions, creams, gels and foams may be delivered into the vagina, and the suppositories can be delivered into the vagina or into the rectal canal. The copper ion lotions, creams, gels, foams and solutions may also be topically applied to the external genital and/or rectal areas.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Inventors: Chun Lim Abbott, Dominic C. Abbott
-
Publication number: 20140200553Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.Type: ApplicationFiled: January 15, 2013Publication date: July 17, 2014Applicant: PALO ALTO RESEARCH CENTER INCORPORATEDInventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
-
Patent number: 8734409Abstract: Provided is an apparatus that includes a scaffold with a gel or liquid composition deposed on at least a portion of a luminal surface, the gel or liquid composition adapted to include microbubbles. Also provided is a system that includes a source of reduced pressure, the above scaffold, a manifold adjacent the scaffold, and a conduit for providing fluid communication between the manifold and the source of reduced pressure. Additionally provided is a method that includes implanting the above scaffold at the tissue site and disrupting a substantial portion of the microbubbles to induce fluid flow to the scaffold. Further provided is an apparatus that includes a scaffold that comprises a slowly degradable material and a quickly degradable material. Additionally provided is a system for coupling nerve tissue and a microchip assembly.Type: GrantFiled: December 29, 2009Date of Patent: May 27, 2014Assignee: KCI Licensing, Inc.Inventors: Larry D Swain, Michael E Manwaring, Douglas A. Cornet, Braden K Leung
-
Publication number: 20140142520Abstract: The present disclosure relates to implantable medical devices which include at least one mesh and at least one film pivotably attached to the mesh.Type: ApplicationFiled: November 12, 2013Publication date: May 22, 2014Applicant: Covidien LPInventors: Joshua STOPEK, Amin ELACHCHABI, Daniel BROOM, Garrett EBERSOLE, Ryan WITHERELL
-
Patent number: 8617139Abstract: Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications. The implant can be reversibly deformed to a first shape, such as a generally linear shape conducive to insertion. Upon insertion, the implant can deform to a second shape, such as a generally non-linear shape conducive to retention within the eye. The shape also improves fluid flow from the anterior chamber and prevents or reduces clogging.Type: GrantFiled: June 25, 2009Date of Patent: December 31, 2013Assignee: Transcend Medical, Inc.Inventors: Thomas A. Silvestrini, Steven John, Jose Garcia, Richard S. Lilly
-
Publication number: 20130345678Abstract: A method, medicated feminine sanitary products and compositions for reducing menstrual blood loss in a female are provided. The method comprises delivering an active agent to the uterine cavity by administering intravaginally to the female a therapeutically effective amount of the active agent on a medicated feminine sanitary product during menstrual bleeding, wherein the medicated feminine sanitary product is routinely utilized to absorb the menstrual flow, wherein the active agent is incorporated in the medicated feminine sanitary product as a pharmaceutically acceptable composition, the active agent is any of an antifibrinolytic and a hemostatic agent.Type: ApplicationFiled: August 22, 2013Publication date: December 26, 2013Applicant: ARSTAT Inc.Inventor: Arkady RUBIN
-
Publication number: 20130237933Abstract: The present invention relates to a tampon structure, the tampon structure comprise at least one absorbent carbonaceous base with at least two precious metals, an absorber, a surface layer, and a rope. The copper ions and silver ions can be released by the at least two precious metals in aqueous solution to reach the health effects of the female vagina.Type: ApplicationFiled: November 5, 2012Publication date: September 12, 2013Applicant: FENG CHIA UNIVERSITYInventor: TSE-HAO KO
-
Patent number: 8444588Abstract: A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.Type: GrantFiled: February 23, 2010Date of Patent: May 21, 2013Assignee: Transcend Medical, Inc.Inventor: Michael Yablonski
-
Publication number: 20130030392Abstract: A device and a method for manufacturing said device, the device comprising an applicator member and a flexible retention web (1) intended to be introduced into a vaginal cavity (17), said web being equipped with a means (7) for removal and being made from an atraumatic material whereof the dimensions are adapted so as to be able to retain and/or slow down bodily discharges of small quantity, characterized in that: the applicator member comprises a body (8) that is at least partially hollow defining an internal storage volume (9), said body having a proximal end (10) on the one hand, and on the other hand, a distal end (11) intended to be inserted into the vaginal cavity of a user, said distal end having an open section emerging in the internal volume, the web comprises a central zone (13) housed in the internal volume, and at least one peripheral zone (14) protruding from the body so as to cover at least the distal end of the body.Type: ApplicationFiled: February 21, 2012Publication date: January 31, 2013Applicant: BTAMPON IPInventors: Bernard CHAFFRINGEON, Richard GUETTY
-
Publication number: 20120270936Abstract: A composition, employed topically for its microbicidal, spermatocidal activity upon application to the human genitalia and/or anorectal area, and the relief from symptoms of local inflammation and infection incorporates L-Ascorbic acid in a concentration of about 2% to about 25% wt/vol, within an acidic range or pH level of about 4.0 to 2.0 pH respectively, in an aqueous solution with a pharmaceutically acceptable liquid carrier. In alternative exemplary includes a synergistic antioxidant and further incorporates enhancing bioactive ingredients. The method for topical application of the composition includes douche, rinse, cream, gel, suppository, saturated tampon and externally saturated condom for treatment of the vagina; drops, spray, cleansing wipe, cream, gel and internally saturated condom for treatment of the penis; and cleansing wipe, gel, suppository and externally saturated condom for male genitalia and rectum.Type: ApplicationFiled: April 9, 2012Publication date: October 25, 2012Inventor: Joseph Di Bartolomeo
-
Patent number: 8293232Abstract: A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site.Type: GrantFiled: January 19, 2012Date of Patent: October 23, 2012Assignee: Warsaw Orthopedic, Inc.Inventors: Neil B. Beals, Jeffrey L. Scifert, Scott D. Boden
-
Publication number: 20120220544Abstract: A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinson's disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.Type: ApplicationFiled: February 28, 2012Publication date: August 30, 2012Inventors: Jay S. Schneider, John J. Koleng, Robert Florentine, David W. Anderson
-
Patent number: 8206333Abstract: The present invention relates to an ocular implant, particularly a glaucoma stent. It is the object of the present invention to devise an ocular implant which allows the ocular eye pressure to be regulated, i.e., to be maintained at a desired level, while preventing the flow resistance from increasing over time, for example due to fibrosis. In order to achieve this object, the ocular implant according to the invention comprises a small tube (5), the wall surface (3) of which encloses a hollow duct that is open on both sides in the longitudinal direction of the hollow duct, wherein a first opening (1) allowing ocular humor to flow in and a second opening (2) allowing the ocular humor to be discharged is provided, and wherein the wall surface (3) is formed by a liquid-tight material, and wherein at least one pressure-controlled valve (4) is disposed in the area of the wall surface (3).Type: GrantFiled: January 25, 2008Date of Patent: June 26, 2012Assignee: Universitaet RostockInventors: Wolfram Schmidt, Katrin Sternberg, Detlef Behrend, Rudolf Guthoff, Klaus-Peter Schmitz
-
Patent number: 8198238Abstract: A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site.Type: GrantFiled: September 15, 2011Date of Patent: June 12, 2012Assignee: Warsaw Orthopedic, Inc.Inventors: Neil B. Beals, Jeffrey L. Scifert, Scott D. Boden
-
Publication number: 20120071839Abstract: A tampon has an absorbent body that absorbs liquid. The absorbent body includes, on its outer surface, an applied portion to which an agent is applied. The agent is a mixture of an active pharmaceutical ingredient, a first water-soluble carrier that carries the active pharmaceutical ingredient and is a main ingredient of the agent, and a second water-soluble carrier that carries the active pharmaceutical ingredient and has a melting point lower than that of the first water-soluble carrier.Type: ApplicationFiled: March 10, 2010Publication date: March 22, 2012Applicant: UNI-CHARM CORPORATIONInventors: Mitsuhiro Wada, Satoshi Nozaki
-
Patent number: 8137327Abstract: A vaginal drug delivery system includes a device formed of porous material that holds a flowable therapeutic formulation. The device, preferably in a soft, prewetted state, is inserted into the vagina to reside typically at or near the cervix where it continuously releases the flowable therapeutic formulation through its outer surface which is in contact with the vaginal surfaces. In operation, the flowable therapeutic formulation migrates via capillary forces from a reservoir that is centrally located in the device and through a covering that envelopes the reservoir.Type: GrantFiled: June 16, 2006Date of Patent: March 20, 2012Assignee: Family Health InternationalInventors: David C. Sokal, Carol L. Joanis, George A. M. Butterworth, James D. Reed, Robert A. Johnson
-
Patent number: 8080521Abstract: A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site.Type: GrantFiled: December 23, 2010Date of Patent: December 20, 2011Assignee: Warsaw Othopedic, Inc.Inventors: Neil B. Beals, Jeffrey L. Scifert, Scott D. Boden
-
Patent number: 8076529Abstract: An intraluminal catheter device having an expandable member formed of a matrix of fiber elements with a therapeutic agent incorporated therein. The therapeutic agent can be coated on the fiber elements in a co-axial configuration. The fiber elements may also have a second coating including a protective substance surrounding the therapeutic agent. The matrix of fiber elements can be formed by electrospinning. A process of delivering a therapeutic agent to a target site includes providing an intraluminal catheter device having an expandable member formed of a matrix of fiber elements, the expandable member having a therapeutic agent dispersed therein, and advancing the catheter device at a desired treatment site. Once at the desired treatment site, fluid is introduced into the inflation lumen to expand the expandable member from a first profile to a second profile, and the therapeutic agent is delivered to the desired treatment site.Type: GrantFiled: September 26, 2008Date of Patent: December 13, 2011Assignee: Abbott Cardiovascular Systems, Inc.Inventors: Kevin J. Ehrenreich, Richard R. Newhauser, Randolf von Oepen, John Stankus
-
Patent number: 8049061Abstract: An intraluminal catheter device having an expandable member formed of a matrix of fiber elements, the expandable member including a hydrogel polymer having a therapeutic agent incorporated therein. The hydrogel polymer can be coated on the fiber elements in a co-axial configuration. The fiber elements may also have a second coating including a protective substance surrounding the hydrogel polymer having a therapeutic agent therein. The matrix of fiber elements can be formed by electrospinning. A process of delivering a therapeutic agent to a target site includes providing an intraluminal catheter device having an expandable member formed of a matrix of fiber elements, the expandable member including a hydrogel polymer having a therapeutic agent dispersed therein, and advancing the catheter device at a desired treatment site.Type: GrantFiled: September 25, 2008Date of Patent: November 1, 2011Assignee: Abbott Cardiovascular Systems, Inc.Inventors: Kevin J. Ehrenreich, Richard R. Newhauser, Randolf von Oepen, John Stankus
-
Publication number: 20110125109Abstract: A device for introducing a haemostatic agent into a penetrating wound. The device includes an elongate introducing member and a haemostatic agent applied to the elongate introducing member. The haemostatic agent may be applied to the introducing member using a flexible membrane, configured to be rolled around the elongate introducing member, a biocompatible foam, or a gel.Type: ApplicationFiled: November 10, 2010Publication date: May 26, 2011Inventor: Erik B. Young
-
Patent number: 7897564Abstract: A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site.Type: GrantFiled: December 9, 2009Date of Patent: March 1, 2011Inventors: Neil B. Beals, Jeffrey L. Scifert, Scott D. Boden
-
Publication number: 20110046571Abstract: The present invention provides an absorbing pad for indicating saturation. The pad comprises inter alia from at least one absorbent body, at least one saturation sensor embedded within said absorbent body and at least one saturation indicator connected to said saturation sensor, embedded within said absorbent body wherein said indicator is adapted to provide information to the user as to the degree of saturation of said pad without removing the pad from its application.Type: ApplicationFiled: April 15, 2008Publication date: February 24, 2011Inventor: Joshua Waldhorn
-
Patent number: 7824383Abstract: A vaginal drug delivery system includes a device formed of porous material that holds a flowable therapeutic formulation. The device, preferably in a soft, prewetted state, is inserted into the vagina to reside typically at or near the cervix where it continuously releases the flowable therapeutic formulation through its outer surface which is in contact with the vaginal surfaces. In operation, the flowable therapeutic formulation migrates via capillary forces from a reservoir that is centrally located in the device and through a covering that envelopes the reservoir.Type: GrantFiled: June 14, 2007Date of Patent: November 2, 2010Assignee: Family Health InternationalInventors: David C. Sokal, Carol L. Joanis, George A. M. Butterworth, James D. Reed, Robert A. Johnson
-
Patent number: 7723291Abstract: A pump to deliver bone-growth factors to a carrier matrix within a patient. Pump can be internal or external. With external pumps, additional amounts of the same growth factor may be added, or the bioactive agent may be changed during the course of treatment. An external pump permits the use of cells to promote bone growth. The pump can have several reservoirs and the pump can itself be received in the carrier matrix with an outlet tube or other structure to defuse the growth factors into the carrier matrix. The pump protocol can be used for slow-to-heal fractures, such as closed fractures, and can be used for slow-to-heal patients.Type: GrantFiled: July 27, 2006Date of Patent: May 25, 2010Inventors: Neil Beals, Jeffrey L. Scifert, Vanja M. King
-
Patent number: 7717892Abstract: A method for treating urinary incontinence includes the steps of inserting into the woman's vagina a first disposable device, removing the first disposable device, and inserting a second disposable device substantially identical to the first disposable device. The disposable devices have a generally cylindrical working portion with opposed faces to provide support to an associated urinary system and an anchoring portion to maintain the disposable device in place during use. The working portion also has an initial equivalent diameter ranging from about 20 to about 170 mm, an insertion equivalent diameter ranging from about 5 to about 25 mm, a use equivalent diameter ranging from about 20 to about 40 mm and a length ranging from about 20 to about 60 mm.Type: GrantFiled: July 10, 2006Date of Patent: May 18, 2010Assignee: McNeil-PPC, Inc.Inventors: Michelle Bartning, Kevin F. Gironda, Mari Hou, Thomas P. Luchino, Kirsten Freislinger Luehrs, Pramod Mavinkurve, Leonard Rosenfeld, Raymond J. Hull, Jr., David J. Chase
-
Publication number: 20100121285Abstract: For applying medications in the form of active substances bound in a liquid or paste-like matrix in the ear canal, a means for absorbing and locally delivering a medication. The means includes a sack-like receptacle part in which a preferably textile tampon able to absorb the medication can be accommodated, and an elastic rubber retaining washer serving to fix the receptacle part in the outer ear. The receptacle part is firmly connected to a pulling device, such as a string, via the retaining washer. The retaining washer fixes the receptacle part in the outer ear canal and is thus supported on one side behind the anthelix and on the other side behind the tragus. In one embodiment, the retaining washer is made from a flat material stamped from foam rubber. The applicator can be sold with a charge of medication.Type: ApplicationFiled: May 7, 2009Publication date: May 13, 2010Inventors: Oskar E. Illi, Clarence P. Feldmann
-
Patent number: 7671014Abstract: A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site.Type: GrantFiled: August 14, 2006Date of Patent: March 2, 2010Inventors: Neal Beals, Jeffrey L. Scifert, Scott D. Boden
-
Patent number: 7655831Abstract: A method and device for shunting fluid from high pressure volumes to low pressure volumes to treat various medical problems caused by an imbalance or malfunction of the regulation of flow between these volumes. Typical problems where the method and device are employed include the treatment of incontinence, treatment of hydrocephalus, treatment of elevated intra-cranial pressure, treatment of elevated intra-ocular pressure and the like. The controlled release of fluid from the high pressure volume is accomplished by inserting a sponge using an insertion device such as an endoscope. The sponge retains and releases fluid in response to a pressure differential between the high and lower pressure volumes. The sponge material may be natural or synthetic and sponges with different porosity and fluid retention are provided to achieve desired flow characteristics.Type: GrantFiled: October 18, 2006Date of Patent: February 2, 2010Inventor: Arnold S. Prywes
-
Publication number: 20090131909Abstract: An absorbent article, e.g. tampons, sanitary napkins, panty liners and the like, and the process for their preparation in which a hydrophobic and/or cationactive layer is attached to a conventional absorbent layer, for the binding of microorganisms, specifically for treating or alleviating or prophylactically preventing vaginal fungal infections.Type: ApplicationFiled: November 5, 2008Publication date: May 21, 2009Inventors: Sten Bjornberg, Jan G. Smith